Overview

Prospective Study of Lopinavir Based ART for HIV Infected childreN Globally (LIVING Study)

Status:
Completed
Trial end date:
2019-05-14
Target enrollment:
Participant gender:
Summary
The study will be carried out to provide supportive clinical data on the feasibility, efficacy, safety, and PK of LPV based therapies in routine treatment setting and will be based on the existing LPV/r pellets which already represent a clear advantage in comparison with the liquid formulation.
Phase:
Phase 3
Details
Lead Sponsor:
Drugs for Neglected Diseases
Collaborators:
French Development Agency
UNITAID
Treatments:
Lopinavir